[Federal Register Volume 72, Number 85 (Thursday, May 3, 2007)]
[Notices]
[Pages 24608-24611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-8422]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-290R]


Controlled Substances: Proposed Revised Aggregate Production 
Quotas for 2007

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of proposed revised 2007 aggregate production quotas.

-----------------------------------------------------------------------

SUMMARY: This notice proposes revised 2007 aggregate production quotas 
for controlled substances in schedules I and II of the Controlled 
Substances Act (CSA).

DATES: Written comments must be postmarked, and electronic comments 
must be sent, on or before May 24, 2007.

ADDRESSES: To ensure proper handling of comments, please reference 
``Docket No. DEA-290R on all written and electronic correspondence. 
Written comments being sent via regular mail should be sent to the 
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration, Washington, DC 20537, Attention: DEA 
Federal Register Representative/ODL. Written comments sent via express 
mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
VA 22301. Comments may be directly sent to DEA electronically by 
sending an electronic message to [email protected]. 
Comments may also be sent electronically through http://www.regulations.gov using the electronic comment form provided on that 
site. An electronic copy of this

[[Page 24609]]

document is also available at the http://www.regulations.gov Web site. 
DEA will accept attachments to electronic comments in Microsoft Word, 
WordPerfect, Adobe PDF, or Excel file formats only. DEA will not accept 
any file format other than those specifically listed here.

FOR FURTHER INFORMATION CONTACT: Christine A. Sannerud, PhD, Chief, 
Drug and Chemical Evaluation Section, Drug Enforcement Administration, 
Washington, DC 20537, Telephone: (202) 307-7183.

SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) 
requires that the Attorney General establish aggregate production 
quotas for each basic class of controlled substance listed in schedules 
I and II. This responsibility has been delegated to the Administrator 
of the DEA by 28 CFR 0.100. The Administrator, in turn, has redelegated 
this function to the Deputy Administrator, pursuant to 28 CFR 0.104.
    On December 11, 2006, a notice of established initial 2007 
aggregate production quotas for certain controlled substances in 
schedules I and II was published in the Federal Register (71 FR 71559). 
This notice stipulated that the DEA would adjust the quotas in early 
2007 as provided for in 21 CFR Part 1303.
    The proposed revised 2007 aggregate production quotas represent 
those quantities of controlled substances in schedules I and II that 
may be produced in the United States in 2007 to provide adequate 
supplies of each substance for: The estimated medical, scientific, 
research and industrial needs of the United States; lawful export 
requirements; and the establishment and maintenance of reserve stocks. 
These quotas do not include imports of controlled substances for use in 
industrial processes.
    The proposed revisions are based on a review of 2006 year-end 
inventories, 2006 disposition data submitted by quota applicants, 
estimates of the medical needs of the United States, product 
development, and other information available to the DEA.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the CSA (21 U.S.C. 826), and delegated to the 
Administrator of the DEA by 28 CFR 0.100, and redelegated to the Deputy 
Administrator pursuant to 28 CFR 0.104, the Deputy Administrator hereby 
proposes the following revised 2007 aggregate production quotas for the 
following controlled substances, expressed in grams of anhydrous acid 
or base:

------------------------------------------------------------------------
                                   Previously
   Basic class--Schedule I     established initial    Proposed revised
                                   2007 quotas           2007 quotas
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine....           2,001,000 g           2,001,000 g
2,5-Dimethoxy-4-                                 2                     2
 ethylamphetamine (DOET)....
2,5-Dimethoxy-4-(n)-                            10                    10
 propylthiophenethylamine
 (2C-T-7)...................
3-Methylfentanyl............                     2                     2
3-Methylthiofentanyl........                     2                     2
3,4-Methylenedioxyamphetamin                    20                    20
 e (MDA)....................
3,4-Methylenedioxy-N-                           10                    10
 ethylamphetamine (MDEA)....
3,4-Methylenedioxymethamphet                    22                    22
 amine (MDMA)...............
3,4,5-Trimethoxyamphetamine.                     2                     2
4-Bromo-2,5-                                     2                     2
 dimethoxyamphetamine (DOB).
4-Bromo-2,5-                                     7                     2
 dimethoxyphenethylamine (2-
 CB)........................
4-Methoxyamphetamine........                    77                    77
4-Methylaminorex............                     2                     2
4-Methyl-2,5-                                   12                    12
 dimethoxyamphetamine (DOM).
5-Methoxy-3,4-                                   2                     2
 methylenedioxyamphetamine..
5-Methoxy-N,N-                                   5                     5
 diisopropyltryptamine......
Acetyl-alpha-methylfentanyl.                     2                     2
Acetyldihydrocodeine........                     2                     2
Acetylmethadol..............                     2                     2
Allylprodine................                     2                     2
Alphacetylmethadol..........                     2                     2
Alpha-ethyltryptamine.......                     2                     2
Alphameprodine..............                     2                     2
Alphamethadol...............                     3                     3
Alpha-methylfentanyl........                     2                     2
Alpha-methylthiofentanyl....                     2                     2
Alpha-methyltryptamine......                     5                     5
Aminorex....................                     8                     8
Benzylmorphine..............                     2                     2
Betacetylmethadol...........                     2                     2
Beta-hydroxy-3-                                  2                     2
 methylfentanyl.............
Beta-hydroxyfentanyl........                     2                     2
Betameprodine...............                     2                     2
Betamethadol................                     2                     2
Betaprodine.................                     2                     2
Bufotenine..................                     8                     8
Cathinone...................                     3                     3
Codeine-N-oxide.............                   302                   302
Diethyltryptamine...........                     2                     2
Difenoxin...................                    50                    50
Dihydromorphine.............             2,549,000             2,549,000
Dimethyltryptamine..........                     3                     3
Gamma-hydroxybutyric acid...            13,100,000            13,100,000
Heroin......................                     5                     5
Hydromorphinol..............                 3,000                 3,000
Hydroxypethidine............                     2                     2
Ibogaine....................                     1                     1

[[Page 24610]]

 
Lysergic acid diethylamide                      61                    61
 (LSD)......................
Marihuana...................             4,500,000             4,500,000
Mescaline...................                     2                     2
Methaqualone................                    10                    10
Methcathinone...............                     4                     4
Methyldihydromorphine.......                     2                     2
Morphine-N-oxide............                   310                   310
N,N-Dimethylamphetamine.....                     7                     7
N-Ethylamphetamine..........                     2                     2
N-Hydroxy-3,4-                                   2                     2
 methylenedioxyamphetamine..
Noracymethadol..............                     2                     2
Norlevorphanol..............                    52                    52
Normethadone................                     2                     2
Normorphine.................                    16                    16
Para-fluorofentanyl.........                     2                     2
Phenomorphan................                     2                     2
Pholcodine..................                     2                     2
Psilocybin..................                     7                     7
Psilocyn....................                     7                     7
Tetrahydrocannabinols.......               312,500               312,500
Thiofentanyl................                     2                     2
Trimeperidine...............                     2                     2
------------------------------------------------------------------------


------------------------------------------------------------------------
                                   Previously
  Basic class--Schedule II     established initial    Proposed revised
                                   2007 quotas           2007 quotas
------------------------------------------------------------------------
1-Phenylcyclohexylamine.....                   2 g                   2 g
Alfentanil..................                 7,200                 7,200
Alphaprodine................                     2                     2
Amobarbital.................                     3                     3
Amphetamine (for sale)......            17,000,000            17,000,000
Amphetamine (for conversion)                     0             2,760,000
Cocaine.....................               286,000               286,000
Codeine (for sale)..........            39,605,000            39,605,000
Codeine (for conversion)....            59,000,000            59,000,000
Dextropropoxyphene..........           120,000,000           120,000,000
Dihydrocodeine..............             2,435,000             2,435,000
Diphenoxylate...............               828,000               828,000
Ecgonine....................                83,000                83,000
Ethylmorphine...............                     2                     2
Fentanyl....................             1,428,000             1,428,000
Glutethimide................                     2                     2
Hydrocodone (for sale)......            42,000,000            42,000,000
Hydrocodone (for conversion)             1,500,000             1,500,000
Hydromorphone...............             3,300,000             3,300,000
Isomethadone................                     2                     2
Levo-alphacetylmethadol                          6                     6
 (LAAM).....................
Levomethorphan..............                     5                     5
Levorphanol.................                 6,000                 6,000
Lisdexamfetamine............                     0             6,200,000
Meperidine..................             9,753,000             9,753,000
Metazocine..................                     1                     1
Methadone (for sale)........            25,000,000            25,000,000
Methadone Intermediate......            26,000,000            26,000,000
Methamphetamine.............             3,130,000             3,130,000
------------------------------------------------------------------------
[680,000 grams of levo-desoxyephedrine for use in a non-controlled, non-
 prescription product; 2,405,000 grams for methamphetamine mostly for
 conversion to a schedule III product; and 45,000 grams for
 methamphetamine (for sale)]
------------------------------------------------------------------------
Methylphenidate.............          35,000,000 g          35,000,000 g
Morphine (for sale).........            35,000,000            35,000,000
Morphine (for conversion)...           110,774,000           110,774,000
Nabilone....................                 3,002                 3,002
Noroxymorphone (for sale)...                 1,002                 1,002
Noroxymorphone (for                     11,000,000            11,000,000
 conversion)................
Opium.......................             1,400,000             1,400,000
Oxycodone (for sale)........            56,000,000            56,000,000
Oxycodone (for conversion)..            25,000,000            25,000,000
Oxymorphone.................             1,800,000             1,800,000
Oxymorphone (for conversion)            15,300,000            15,300,000
Pentobarbital...............            28,000,000            28,000,000
Phencyclidine...............                 2,021                 2,021
Phenmetrazine...............                     2                     2

[[Page 24611]]

 
Racemethorphan..............                     2                     2
Remifentanil................                 5,000                 5,000
Secobarbital................                     2                     2
Sufentanil..................                12,300                12,300
Thebaine....................           102,000,000           102,000,000
------------------------------------------------------------------------

    The Deputy Administrator further proposes that aggregate production 
quotas for all other schedules I and II controlled substances included 
in 21 CFR 1308.11 and 1308.12 remain at zero.
    All interested persons are invited to submit their comments in 
writing or electronically regarding this proposal following the 
procedures in the ADDRESSES section of this document. A person may 
object to or comment on the proposal relating to any of the above-
mentioned substances without filing comments or objections regarding 
the others. If a person believes that one or more of these issues 
warrant a hearing, the individual should so state and summarize the 
reasons for this belief.
    In the event that comments or objections to this proposal raise one 
or more issues which the Deputy Administrator finds warrant a hearing, 
the Deputy Administrator shall order a public hearing by notice in the 
Federal Register, summarizing the issues to be heard and setting the 
time for the hearing as per 21 CFR 1303.13(c).
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866.
    This action does not preempt or modify any provision of state law; 
nor does it impose enforcement responsibilities on any state; nor does 
it diminish the power of any state to enforce its own laws. 
Accordingly, this action does not have federalism implications 
warranting the application of Executive Order 13132.
    The Deputy Administrator hereby certifies that this action will not 
have a significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601 et seq. 
The establishment of aggregate production quotas for schedules I and II 
controlled substances is mandated by law and by international treaty 
obligations. The quotas are necessary to provide for the estimated 
medical, scientific, research and industrial needs of the United 
States, for export requirements and the establishment and maintenance 
of reserve stocks. While aggregate production quotas are of primary 
importance to large manufacturers, their impact upon small entities is 
neither negative nor beneficial. Accordingly, the Deputy Administrator 
has determined that this action does not require a regulatory 
flexibility analysis.
    This action meets the applicable standards set forth in Sections 
3(a) and 3(b)(2) of Executive Order 12988 Civil Justice Reform.
    This action will not result in the expenditure by State, local, and 
tribal governments, in the aggregate, or by the private sector, of 
$120,000,000 or more in any one year, and will not significantly or 
uniquely affect small governments. Therefore, no actions were deemed 
necessary under the provisions of the Unfunded Mandates Reform Act of 
1995.
    This action is not a major rule as defined by Section 804 of the 
Small Business Regulatory Enforcement Fairness Act of 1996. This action 
will not result in an annual effect on the economy of $100,000,000 or 
more; a major increase in costs or prices; or significant adverse 
effects on competition, employment, investment, productivity, 
innovation, or on the ability of United States-based companies to 
compete with foreign-based companies in domestic and export markets.

    Dated: April 25, 2007.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E7-8422 Filed 5-2-07; 8:45 am]
BILLING CODE 4410-09-P